Assess: Ferritin, B12, folate, homocysteine, vitamin D; Inflammatory markers (CRP, IL-6); Oxygenation, sleep-disordered breathing; Pregnancy, birth and early-feeding history; Toxin and heavy-metal exposure history. Intervene: Correct iron, B12, folate, vitamin D, magnesium, zinc; Treat the inflammatory driver, not just the marker; Restore oxygenation — nasal breathing, sleep apnea; Mitochondrial support: sleep, light, movement, protein.
Symptom connections · 48
Connections describe mechanisms, not proof that a molecule causes a symptom. Tissue, regulation and clinical context matter.
PCOS (PMOS)Indirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Adipose IL-6/TNF worsens IR and ovarian dysfunction.
Hashimoto'sIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Cytokines suppress deiodinases.
Thyroid dysfunctionIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → T3: Neurotransmitters, hormones & synaptic transmission is assessed and treated through t3. · emerging
The biologically active hormone at the cell.
EndometriosisIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Peritoneal cytokine milieu is highly inflamed.
DepressionIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
IL-6/TNF drive sickness behaviour.
Brain fogIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Neurons are the most ATP-hungry cells.
InsomniaIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → Melatonin: Neurotransmitters, hormones & synaptic transmission is assessed and treated through melatonin. · emerging
Evening light suppresses DLMO.
ADHDIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Ferritin: Molecular, genetic & metabolic foundations is assessed and treated through ferritin. · emerging
Stores gate TH iron availability.
ASD (systems view)Indirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Mitochondrial dysfunction elevated in ASD cohorts.
Brain injury / TBI recoveryIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Post-TBI metabolic crisis is mitochondrial.
AnxietyIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → GABA: Neurotransmitters, hormones & synaptic transmission is assessed and treated through gaba. · emerging
Tonic inhibition sets the resting alarm level.
MigraineIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Riboflavin/CoQ10 responsiveness suggests mito basis.
Leaky gut / intestinal permeabilityIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Breastfeeding: Molecular, genetic & metabolic foundations is assessed and treated through breastfeeding. · emerging
Breastfeeding → Gut barrier: sIgA and lactoferrin support neonatal barrier maturation. · established
The barrier is the outcome — read it downstream.
ConstipationIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → Thyroid: Neurotransmitters, hormones & synaptic transmission is assessed and treated through thyroid. · emerging
Hypothyroidism slows peristalsis.
Antibiotic exposureIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Some antibiotics (fluoroquinolones, aminoglycosides) directly hit mitochondria.
Mast cell activationIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Priming environment for MC hyperactivity.
AutoimmunityIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Epigenetics: Molecular, genetic & metabolic foundations is assessed and treated through epigenetics. · emerging
Exposures set risk before symptom onset.
LipedemaIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Adipose inflammation is central.
Chronic fatigueIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
ATP output ceiling.
Long COVIDIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Viral protein interference with ETC.
POTS / dysautonomiaIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → Norepinephrine: Neurotransmitters, hormones & synaptic transmission is assessed and treated through norepinephrine. · emerging
Hyperadrenergic subtype.
IBSIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Birth: Molecular, genetic & metabolic foundations is assessed and treated through birth. · emerging
Birth → Microbiome: Vaginal delivery seeds infant microbiome. · established
Dysbiosis / SIBO common.
HypertensionIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
IL-6/CRP correlate with vascular stiffness.
Cardiovascular diseaseIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Oxidative stress: Molecular, genetic & metabolic foundations is assessed and treated through oxidative_stress. · emerging
Oxidised LDL triggers macrophage uptake.
HyperlipidemiaIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → Thyroid: Neurotransmitters, hormones & synaptic transmission is assessed and treated through thyroid. · emerging
Hypothyroid state raises LDL.
DementiaIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Neuronal ATP failure precedes atrophy.
Bipolar disorderIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Bioenergetic dysfunction in cortical neurons.
PTSDIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → Norepinephrine: Neurotransmitters, hormones & synaptic transmission is assessed and treated through norepinephrine. · emerging
Hyper-noradrenergic reactivity.
Graves' diseaseIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → L2 — Neurotransmitters, hormones & synaptic transmission: Level 1 is a substrate for level 2 — each level builds on the one below. · emerging
L2 — Neurotransmitters, hormones & synaptic transmission → Thyroid: Neurotransmitters, hormones & synaptic transmission is assessed and treated through thyroid. · emerging
TSI antibodies overstimulate follicular cells.
Cushing syndromeIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Mitochondria → Cortisol: StAR imports cholesterol; CYP11A1 launches steroidogenesis. · established
Sustained hypercortisolism is the causal engine.
Addison's diseaseIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Autoimmune adrenalitis is the leading cause.
DysmenorrheaIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
PGF2α drives cramping.
Female infertilityIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Endometrial receptivity requires low background inflammation.
Pre-eclampsiaIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Placenta: Molecular, genetic & metabolic foundations is assessed and treated through placenta. · emerging
Shallow trophoblast invasion → ischemia.
Uterine fibroids (leiomyoma)Indirect connection · established
L1 — Molecular, genetic & metabolic foundations → Environmental toxins: Molecular, genetic & metabolic foundations is assessed and treated through environmental_toxins. · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Drives fibroid growth via ERα.
Metabolic syndromeIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Adipose IL-6/TNF worsens IR.
Type 2 diabetesIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Muscle mitochondrial dysfunction impairs glucose disposal.
ObesityIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Adipose inflammation is both cause and consequence.
Rheumatoid arthritisIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Homocysteine: Molecular, genetic & metabolic foundations is assessed and treated through homocysteine. · emerging
Homocysteine → IL-6: Hyperhomocysteinemia drives endothelial inflammation. · emerging
Sustains synovial inflammation.
Systemic lupus erythematosusIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Cytokine storms during flares.
Multiple sclerosisIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
Systemic + CNS cytokines.
FibromyalgiaIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Mitochondria: Molecular, genetic & metabolic foundations is assessed and treated through mito. · emerging
Reduced muscle ATP capacity.
PsoriasisIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Breastfeeding: Molecular, genetic & metabolic foundations is assessed and treated through breastfeeding. · emerging
Breastfeeding → Gut barrier: sIgA and lactoferrin support neonatal barrier maturation. · established
Leaky gut fuels systemic Th17.
Atopic dermatitisIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Chronic inflammation: Molecular, genetic & metabolic foundations is assessed and treated through chronic_inflammation. · emerging
IL-4/IL-13 axis is the therapeutic target.
Allergic rhinitisIndirect connection · emerging
L1 — Molecular, genetic & metabolic foundations → Breastfeeding: Molecular, genetic & metabolic foundations is assessed and treated through breastfeeding. · emerging
Breastfeeding → Gut barrier: sIgA and lactoferrin support neonatal barrier maturation. · established
Gut permeability tunes mucosal tolerance.
Celiac diseaseIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Cobalamin (B12): Molecular, genetic & metabolic foundations is assessed and treated through vit_b12. · emerging
Terminal ileal involvement can lower B12.
Ulcerative colitisIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Breastfeeding: Molecular, genetic & metabolic foundations is assessed and treated through breastfeeding. · emerging
Breastfeeding → Gut barrier: sIgA and lactoferrin support neonatal barrier maturation. · established
Mucin + tight-junction failure.
Crohn's diseaseIndirect connection · established
L1 — Molecular, genetic & metabolic foundations → Breastfeeding: Molecular, genetic & metabolic foundations is assessed and treated through breastfeeding. · emerging
Breastfeeding → Gut barrier: sIgA and lactoferrin support neonatal barrier maturation. · established
Paneth cell defects impair antimicrobial peptides.